A Clinical Development Paradigm to Improve Patient Engagement

This white paper discusses current challenges of traditional clinical trials, the emergence of eClinical applications and microservices that can enable virtual trials, barriers to adoption of innovative study delivery models and the role of contract research organizations (CROs) in partnering with biopharma to unlock the benefits of virtual trials and maximize trial efficiency. There is no question that hybrid/virtual trials (HVT) or decentralized clinical trials (DCT) have gained momentum since the first hybrid trials were launched in 2001. The industry is working aggressively to identify tools, partners, data and infrastructure required to enable site-less trials. The best partners will be CROs that have diverse capabilities in drug development and beyond, have access to data that can generate insights, enabling them to lead the way in the development of patient and sponsor support ecosystems that deliver better, more efficient trials.